These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11588380)

  • 1. Two intermediates in the synthesis of decahydroisoquinolines with NMDA and AMPA receptor antagonist activity.
    Zukerman-Schpector J; Vega M; Caracelli I; Dias LC; Fernandes AM
    Acta Crystallogr C; 2001 Sep; 57(Pt 9):1089-91. PubMed ID: 11588380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor.
    Cruz LA; Estébanez-Perpiñá E; Pfaff S; Borngraeber S; Bao N; Blethrow J; Fletterick RJ; England PM
    J Med Chem; 2008 Sep; 51(18):5856-60. PubMed ID: 18754610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
    Ornstein PL; Arnold MB; Allen NK; Leander JD; Tizzano JP; Lodge D; Schoepp DD
    J Med Chem; 1995 Dec; 38(25):4885-90. PubMed ID: 8523401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Carling RW; Leeson PD; Moore KW; Smith JD; Moyes CR; Mawer IM; Thomas S; Chan T; Baker R; Foster AC
    J Med Chem; 1993 Oct; 36(22):3397-408. PubMed ID: 8230130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one.
    Bruno G; Nicoló F; Rotondo A; Gitto R; Zappalá M
    Acta Crystallogr C; 2001 Oct; 57(Pt 10):1225-7. PubMed ID: 11600794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
    Calabri FR; Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A
    Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
    Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.
    Gitto R; Barreca ML; De Luca L; De Sarro G; Ferreri G; Quartarone S; Russo E; Constanti A; Chimirri A
    J Med Chem; 2003 Jan; 46(1):197-200. PubMed ID: 12502375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists.
    Büttelmann B; Alanine A; Bourson A; Gill R; Heitz MP; Mutel V; Pinard E; Trube G; Wyler R
    Bioorg Med Chem Lett; 2003 Mar; 13(5):829-32. PubMed ID: 12617901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of argiotoxin 636 and analogues: selective antagonists for ionotropic glutamate receptors.
    Nelson JK; Frølund SU; Tikhonov DB; Kristensen AS; Strømgaard K
    Angew Chem Int Ed Engl; 2009; 48(17):3087-91. PubMed ID: 19152392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.
    Colotta V; Catarzi D; Varano F; Calabri FR; Filacchioni G; Costagli C; Galli A
    Bioorg Med Chem Lett; 2004 May; 14(9):2345-9. PubMed ID: 15081038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemically knocking out glutamate receptors in vivo.
    Chambers JJ; Gouda H; Young DM; Kuntz ID; England PM
    J Am Chem Soc; 2004 Nov; 126(43):13886-7. PubMed ID: 15506725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2219-31. PubMed ID: 8667365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.
    Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    J Med Chem; 1999 Jul; 42(13):2478-84. PubMed ID: 10395489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position.
    Takano Y; Shiga F; Asano J; Ando N; Uchiki H; Fukuchi K; Anraku T
    Bioorg Med Chem; 2005 Oct; 13(20):5841-63. PubMed ID: 15993606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-(3,4-dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists.
    Büttelmann B; Alanine A; Bourson A; Gill R; Heitz MP; Mutel V; Pinard E; Trube G; Wyler R
    Bioorg Med Chem Lett; 2003 May; 13(10):1759-62. PubMed ID: 12729659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of antagonists for NMDA and AMPA receptors.
    Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
    Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically Modified, α-Amino-3-hydroxy-5-methyl-4-isoxazole (AMPA) Receptor RNA Aptamers Designed for in Vivo Use.
    Huang Z; Wen W; Wu A; Niu L
    ACS Chem Neurosci; 2017 Nov; 8(11):2437-2445. PubMed ID: 28872832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.